tm logo
RUTESPI
Live/Pending
NOTICE OF ALLOWANCE - ISSUED

issued

on 05 Mar 2024

Last Applicant/ Owned by

GSK Medicines Research Centre

Stevenage

GB

SG12NY

Serial Number

97793808 filed on 14th Feb 2023

Registration Number

N/A

Correspondent Address

Elizabeth K. Rucki

GSK

410 BLACKWELL STREET

LEGAL BRAND PROTECTION

DURHAM,NC 27701

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

RUTESPI

Vaccines; Anti-infectives; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatRead More

Classification Information


Class [005]
Pharmaceutical Products


Vaccines; Anti-infectives; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders

Mark Details


Serial Number

No 97793808

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 84211900

44D Filed

No

44D Current

No

44E filed

Yes

44E Current

Yes

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
05th Mar 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
09th Jan 2024PUBLISHED FOR OPPOSITION
09th Jan 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
20th Dec 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05th Dec 2023APPROVED FOR PUB - PRINCIPAL REGISTER
30th Nov 2023TEAS/EMAIL CORRESPONDENCE ENTERED
29th Nov 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
29th Nov 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
13th Nov 2023NON-FINAL ACTION WRITTEN
13th Nov 2023NON-FINAL ACTION E-MAILED